Literature DB >> 7100044

Atrio-ventricular block after administration of lignocaine in patients treated with prenylamine.

E Grenadier, G Alpan, S Keidar, A Palant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7100044      PMCID： PMC2426356          DOI： 10.1136/pgmj.58.677.175

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Ventricular arrhythmias caused by prenylamine.

Authors:  R Puritz; M A Henderson; S N Baker; D A Chamberlain
Journal:  Br Med J       Date:  1977-09-03

2.  The electrophysiologic effects of lidocaine in patients with intraventricular conduction defects.

Authors:  F Kunkel; M Rowland; M M Scheinman
Journal:  Circulation       Date:  1974-05       Impact factor: 29.690

3.  Lidocaine in ventricular arrhythmia.

Authors:  J P Liss; R M Jeresaty; J Nakhoul
Journal:  Am Heart J       Date:  1973-07       Impact factor: 4.749

4.  Effects of lidocaine on refractory periods in man.

Authors:  M E Josephson; A R Caracta; S H Lau; J J Gallagher; A N Damato
Journal:  Am Heart J       Date:  1972-12       Impact factor: 4.749

5.  Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease.

Authors:  R Gianelly; J O von der Groeben; A P Spivack; D C Harrison
Journal:  N Engl J Med       Date:  1967-12-07       Impact factor: 91.245

6.  Effect of lignocaine on conducting system of human heart.

Authors:  S Bekheit; J G Murtagh; P Morton; E Fletcher
Journal:  Br Heart J       Date:  1973-03

7.  Atrioventricular block with lidocaine therapy.

Authors:  E Lichstein; K D Chadda; P K Gupta
Journal:  Am J Cardiol       Date:  1973-02       Impact factor: 2.778

8.  Effect of lignocaine on heart rate in patients with sinus bradycardia associated with proven or suspected acute myocardial infarction.

Authors:  L Rydén; I Cullhed; H Wasir
Journal:  Cardiovasc Res       Date:  1972-11       Impact factor: 10.787

9.  The effect of lidocaine on atrioventricular and intraventricular conduction in man.

Authors:  K M Rosen; S H Lau; M B Weiss; A N Damato
Journal:  Am J Cardiol       Date:  1970-01       Impact factor: 2.778
  9 in total
  3 in total

1.  The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels.

Authors:  Benjamin Hackl; Peter Lukacs; Janine Ebner; Krisztina Pesti; Nicholas Haechl; Mátyás C Földi; Elena Lilliu; Klaus Schicker; Helmut Kubista; Anna Stary-Weinzinger; Karlheinz Hilber; Arpad Mike; Hannes Todt; Xaver Koenig
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.988

Review 2.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

3.  Ventricular tachycardia precipitated by sodium iothalamate (Conray 420) injection during prenylamine treatment: a predictable adverse drug interaction.

Authors:  J S Duncan; L E Ramsay
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.